1WTH

Crystal structure of gp5-S351L mutant and gp27 complex

Summary for 1WTH

• Entry DOI: 10.2210/pdb1wth/pdb
• Related: 1K28
• Descriptor: Tail-associated lysozyme, Baseplate structural protein Gp27, POTASSIUM ION, ... (5 entities in total)
• Functional Keywords: triple-stranded beta-helix, ob fold, pseudohexamer, t4 tail lysozyme, hub, gp5-gp27, hydrolase-structural protein complex, hydrolase/structural protein
• Biological source: Enterobacteria phage T4; More
• Cellular location: Virion (Potential): P17172
• Total number of polymer chains: 2
• Total formula weight: 108905.12

Authors

Kanamaru, S.,Ishiwata, Y.,Suzuki, T.,Rossmann, M.G.,Arisaka, F. (deposition date: 2004-11-23, release date: 2005-03-08, Last modification date: 2023-10-25)

Primary citation

Kanamaru, S.,Ishiwata, Y.,Suzuki, T.,Rossmann, M.G.,Arisaka, F.
Control of bacteriophage t4 tail lysozyme activity during the infection process
J.Mol.Biol., 346:1013-1020, 2005

PubMed Abstract: Bacteriophage T4 has an efficient mechanism for injecting the host Escherichiacoli cell with genomic DNA. Its gene product 5 (gp5) has a needle-like structure attached to the end of a tube through which the DNA passes on its way out of the head and into the host. The gp5 needle punctures the outer cell membrane and then digests the peptidoglycan cell wall in the periplasmic space. gp5 is normally post-translationally cleaved between residues 351 and 352. The function of this process in controlling the lysozyme activity of gp5 has now been investigated. When gp5 is over-expressed in E.coli, two mutants (S351H and S351A) showed a reduction of cleavage products and five other mutants (S351L, S351K, S351Y, S351Q, and S351T) showed no cleavage. Furthermore, in a complementation assay at 20 degrees C, the mutants that had no cleavage of gp5 produced a reduced number of plaques compared to wild-type T4. The crystal structure of the non-cleavage phenotype mutant of gp5, S351L, complexed with gene product 27, showed that the 18 residues in the vicinity of the potential cleavage site (disordered in the wild-type structure) had visible electron density. The polypeptide around the potential cleavage site is exposed, thus allowing access for an E.coli protease. The lysozyme activity is inhibited in the wild-type structure by a loop from the adjacent gp5 monomer that binds into the substrate-binding site. The same inhibition is apparent in the mutant structure, showing that the lysozyme is inhibited before gp5 is cleaved and, presumably, the lysozyme is activated only after gp5 has penetrated the outer membrane.

PubMed: 15701513
DOI: 10.1016/j.jmb.2004.12.042

Experimental method

X-RAY DIFFRACTION (2.8 Å)